Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the United States, discusses the contradictory nature of Trump’s efforts to lower drug prices. …
Patient groups oftentimes serve as the authority on a specific disease when it comes to advancing research. “Without patient perspective, there is no good medical product development,” Rachel Sherman,…
David Peña Castillo is the President and founder of The Mexican Federation of Rare Diseases (FEMEXER). Here he discusses what makes a patients association. When we find a way to…
Pfizer has teamed up with Bain Capital to launch Cerevel Therapeutics, a biopharmaceutical company based in Boston that will focus on developing treatments for a number of central nervous system…
Pharma Giant Johnson & Johnson (J&J) are set to swallow Ci:z, the Japanese skincare and cosmetics firm. In a move to really establish themselves within the Asian skin care…
Following the initiative of the Ministry of Health, Kazakhstan engaged in activities to reform its healthcare legislation. The concept of the updated Kazakhstan Code “On People’s Health and Healthcare System”…
After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research Foundation to support families of those suffering from…
Richie Etwaru is founder and CEO of Hu-manity, whose vision is to empower people to take ownership of their inherent human data. The pharmaceutical industry has never seen the full…
The global drop in oil prices in 2015-2016 hit the Algerian economy – which is heavily reliant on petroleum revenues – hard. The country’s government implemented severe economic cuts across…
Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria…
In 2013, Chinese President Xi Jinping launched the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative, corralling the two Special Administrative Regions (SARs) of Hong Kong and Macao with Guangdong, one…
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on trading regulations during this time of Brexit uncertainty. “If a transition…
See our Cookie Privacy Policy Here
